332 related articles for article (PubMed ID: 30518407)
1. NmeCas9 is an intrinsically high-fidelity genome-editing platform.
Amrani N; Gao XD; Liu P; Edraki A; Mir A; Ibraheim R; Gupta A; Sasaki KE; Wu T; Donohoue PD; Settle AH; Lied AM; McGovern K; Fuller CK; Cameron P; Fazzio TG; Zhu LJ; Wolfe SA; Sontheimer EJ
Genome Biol; 2018 Dec; 19(1):214. PubMed ID: 30518407
[TBL] [Abstract][Full Text] [Related]
2. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
3. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
4. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
[TBL] [Abstract][Full Text] [Related]
5. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
[TBL] [Abstract][Full Text] [Related]
6. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
[TBL] [Abstract][Full Text] [Related]
7. Versatile and efficient genome editing with Neisseria cinerea Cas9.
Liu Z; Chen S; Xie W; Yu H; Lai L; Li Z
Commun Biol; 2022 Nov; 5(1):1296. PubMed ID: 36435853
[TBL] [Abstract][Full Text] [Related]
8. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
[TBL] [Abstract][Full Text] [Related]
9. A Cas9 with PAM recognition for adenine dinucleotides.
Chatterjee P; Lee J; Nip L; Koseki SRT; Tysinger E; Sontheimer EJ; Jacobson JM; Jakimo N
Nat Commun; 2020 May; 11(1):2474. PubMed ID: 32424114
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
[TBL] [Abstract][Full Text] [Related]
12. Efficient Genome and Base Editing in Human Cells Using ThermoCas9.
Trasanidou D; Barendse P; Bouzetos E; de Haan L; Bouwmeester H; Staals RHJ; Mougiakos I; van der Oost J
CRISPR J; 2023 Jun; 6(3):278-288. PubMed ID: 37134217
[TBL] [Abstract][Full Text] [Related]
13. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
14. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
[TBL] [Abstract][Full Text] [Related]
15. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
[TBL] [Abstract][Full Text] [Related]
16. PAM-flexible genome editing with an engineered chimeric Cas9.
Zhao L; Koseki SRT; Silverstein RA; Amrani N; Peng C; Kramme C; Savic N; Pacesa M; Rodríguez TC; Stan T; Tysinger E; Hong L; Yudistyra V; Ponnapati MR; Jacobson JM; Church GM; Jakimo N; Truant R; Jinek M; Kleinstiver BP; Sontheimer EJ; Chatterjee P
Nat Commun; 2023 Oct; 14(1):6175. PubMed ID: 37794046
[TBL] [Abstract][Full Text] [Related]
17. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
[TBL] [Abstract][Full Text] [Related]
18. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
19. Portable CRISPR-Cas9
Goh YJ; Barrangou R
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
[TBL] [Abstract][Full Text] [Related]
20. Compact Cje3Cas9 for Efficient
Chen S; Liu Z; Xie W; Yu H; Lai L; Li Z
CRISPR J; 2022 Jun; 5(3):472-486. PubMed ID: 35686977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
